Allergy

In a recent review, experts answer frequent questions allergists have about conducting proximity challenges in patients with food allergy anxiety.

Patients with hereditary angioedema experience high adherence and persistence rates with berotralstat, lanadelumab, and SC-pdC1-INH for long-term prophylaxis.

AI enhances prediction, diagnosis, and treatment of allergic diseases including asthma, atopic dermatitis, and food allergies, offering personalized, efficient care.

A systematic review suggests introducing denatured or baked egg under supervision could reduce the burden of strict allergen avoidance.

Real-world data show omalizumab, alone or with OIT, is effective and well-tolerated for IgE-mediated food allergy, with high response rates in adults.

Greenspan offers tips in treating seasonal allergies in patients with pulmonary conditions, such as long-COVID, and provides his 2025 spring allergy prediction.

A phase 3 trial found the Viaskin peanut patch effective in desensitizing peanut-allergic children aged 1 – 3 years, regardless of asthma, atopic dermatitis, or other food allergies.

A new study identified 6 distinct CRSwNP endotype clusters, revealing that patients with mixed type 1/3 inflammation experience faster polyp recurrence than those with type 2 inflammation.

Inhalant exposure at work is linked to worse FESS outcomes in CRSwNP patients, with less symptom relief and higher polyp recurrence, a new study finds.

Combining FESS with selective vidian neurectomy improved long-term nasal symptom control, especially nasal itching, in CRSwNP, allergic rhinitis, and asthma.

Ultrasound showed no significant dermis thickness difference at the cubital fossa, yet dust mite-sensitized kids had signs of allergen-driven skin changes.

The AHN Medicine Institute is launching a new Advanced Allergy and Asthma Clinic.

Allergy treatment use increases postpartum depression risk in women with allergic rhinitis, a study found.

Q1 2025 allergy updates: FDA approved the first omalizumab biosimilar, and experts shared insights on peanut immunotherapy and food allergy treatments.

Aquestive’s Anaphylm study showed positive pharmacokinetic results in children and adolescents, supporting its FDA submission.

March Allergy Updates: FDA approved the first biosimilar for omalizumab, epicutaneous and oral immunotherapy trials showed promise, and experts discussed allergy trends.

A study found many anaphylaxis patients didn’t receive adrenaline, the first-line treatment. Adrenaline use correlated with better outcomes in adults and children.

A new study found that the time it takes to diagnose alpha-gal syndrome has improved from 5.3 years to 28 days since 2011, but disparities remain based on education level.

A study found that genetics and environment both influence allergy risk, but environmental factors play a stronger role in the progression of allergic disease.

Patients with hereditary angioedema report greater rates of autoimmune diseases, allergies, and asthma than the general population, highlighting key comorbidities.

Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key allergy updates from the 2025 American Academy of Allergy, Asthma, and Immunology (AAAAI) annual meeting.

Climate change worsens allergies by lengthening pollen seasons, increasing air pollution, and driving new food allergies. Experts offer strategies for clinicians.

A study highlights how food allergies impact adults' mental health and social lives, revealing anxiety, isolation, and the need for better support systems.

Lugar spoke with HCPLive about when to refer patients with suspected ISM to an allergist, highlighting allergic manifestations, diagnostic clues, and misconceptions.